Get started
NIOX GROUP PLC ORD GBP0.0008NIOX GROUP PLC ORD GBP0.0008NIOX GROUP PLC ORD GBP0.0008

NIOX GROUP PLC ORD GBP0.0008

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

NIOX fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NIOX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company